|
|
|
Journal of Bacteriology, April 2002, p . 2225-2234, Vol . 184, No . 8 The Extracellular Transport Signal of the Vibrio cholerae Endochitinase (ChiA) Is a Structural Motif Located between Amino Acids 75 and 555Jason P . Folster and Terry D . Connell* The Witebsky Center for Microbial Pathogenesis and Immunology and Department of Microbiology, School of Medicine and Biomedical Sciences, The University of Buffalo, State University of New York, Buffalo, New York 14214 Received 17 August 2001/ Accepted 20 January 2002
Although a variety of mechanisms have evolved to convey the mature protein across the outer membrane, for many bacteria, translocation is accomplished by the main terminal branch (MTB) of the general secretory pathway (10), otherwise known as the type II system for extracellular transport (25) . The MTB commonly comprises a minimum of 11 proteins which are believed to form a large multimeric complex that extends from the cytoplasmic membrane to the outer membrane, thereby spanning the periplasmic space (25) . MTB systems have been shown to secrete several important virulence factors, including exotoxin A of Pseudomonas aeruginosa (2), aerolysin of Aeromonas salmonicida (36), and pectate lyase of Erwinia chrysanthemi and Erwinia carotovora (20) . In the enteropathogen Vibrio cholerae, the extracellular transport of cholera toxin (CT), an oligomeric heat-labile enterotoxin, is essential for the pathogenesis of the bacterium . Several studies confirmed that secretion of CT is accomplished by the MTB secretory system (22, 28), which is encoded by at least 13 genes, including vcpD in association with the eps cluster of genes (epsCDEFGHIJKLMN) (18, 22, 27, 28) .
The MTB of V . cholerae is one of the more promiscuous type II secretory systems in regard to the types of proteins which are secreted by the bacterium (5) . Unlike many of the type II secretory systems, which transport one or at most two proteins to the extracellular milieu, the MTB of V . cholerae has the capacity to transport at least six proteins, including CT (22, 28), the type I heat-labile enterotoxin (LT-I) of Escherichia coli (22), the type II heat-labile enterotoxins (LT-IIa and LT-IIb) of E . coli (4, 6), one or more proteases (22), and an endochitinase (5) . Polysaccharide transport, which is required for establishment of the rugose phenotype in V . cholerae (1), is also believed to require the eps secretory system . Secretion by the MTB of V . cholerae may not be limited to protein translocation but may extend to the transport of larger multicomponent particles . Release of vibriophage CTX Numerous experiments have established that the MTB of V . cholerae and the MTBs of other bacteria discriminate between secreted and nonsecreted proteins (15, 23, 29) . While the periplasmic space of V . cholerae contains numerous types of proteins, only a few of those are transported across the outer membrane into the extracellular milieu . These data indicated that prospective extracellular proteins of V . cholerae contain an extracellular transport signal (ETS) which directs proteins fated for extracellular transport to the eps-encoded transport machinery . In this study, our efforts were focused on identifying the ETS of ChiA, an 88-kDa extracellular endochitinase which is transported by the eps-encoded MTB of V . cholerae (5) . As ChiA has little or no amino acid homology to either CT or the other secreted proteins of V . cholerae (i.e., LT-I, LT-IIa, or LT-IIb), the ETS of ChiA was not identifiable from comparisons of primary amino acid sequences . Rather, a genetic approach was used to delimit the region(s) of ChiA which was essential for secretion . From these studies, it was revealed that a region of ChiA located between amino acids 75 and 555 was necessary and sufficient to promote secretion by the eps-encoded secretory machinery of V . cholerae . Furthermore, these studies lent further credence to the hypothesis that the ETS of ChiA is likely a structural motif whose conformation requires the interaction of distally located regions of the protein .
Engineering of ChiA truncations. pTDCC2 was used as the source of the chiA gene for engineering pJPF2, N-terminal truncations, and C-terminal truncations of chiA . To construct pJPF2, pTDCC2 was digested with SstI and HindIII to produce a 2.9-kbp fragment encoding chiA . The 2.9-kbp fragment was directionally ligated into pBluescript SKII+ (Stratagene, La Jolla, Calif.) . The fragment was orientated in pJPF2 so that expression of chiA was under control of the vector's lac promoter (Plac) . Synthetic oligonucleotides and PCR were used to engineer all truncation mutants of chiA . pTDCC2 which had been linearized by digestion with KpnI was used as a template . The upstream oligonucleotide primer used to engineer all six C-terminal truncations was Blue-619 (5'-GTAAAACGACGGCCAGTGA-3'), which was homologous to sequences located in the multicloning region of the vector . The downstream oligonucleotide for each truncation was synthesized with an in-frame TAA translational stop codon (bold) and an EcoRI restriction site (underlined) . The nucleotide sequences of the downstream oligonucleotides were as follows: chiA756, 5'-GGAATTCTTACCCGTTGGCTAAAGT-3'; chiA608, 5'-GGAATTCTTAAAGCGCCACCTAAGGAAA-3'; chiA555, 5'-GGAATTCTTAAAAGGCAATATCAATCAC-3'; chiA478, 5'-GGAATTCTTAAGGCTCTGTTGTATCC-3'; chiA378, 5'-GGAATTCTTAGTTGTTGCCCGCAAAA-3'; and chiA179, 5'-GGAATTCTTATGGCGGAACTGGGTTA-3' . DNA amplification reactions were performed with a DNA thermal cycler model 480 (Perkin-Elmer, Norwalk, Conn.) . Conditions for the reactions were: denaturation at 92°C for 30 s, annealing at 54°C for 45 s, and extension at 72°C for 3 min . Amplified DNA fragments were resolved by electrophoresis on 0.8% agarose gels and isolated from gel slices using a GeneClean II kit (Bio 101, Inc., Vista, Calif.) . DNA fragments digested with XbaI and EcoRI were directionally ligated into pBluescript SKII+ so that expression of the engineered genes was under control of Plac . The 3' ends of the truncated genes were confirmed by nucleotide sequencing . To engineer the N-terminal truncations, an intermediate plasmid containing the signal sequence of ChiA was constructed . Primers Chi-15 (5'-GGAATTCCGAAAAAGAATTGAAAGC-3', EcoRI site underlined) and chi3'V28 (5'-CATCTAGACACTCCGGCACAGTTAT-3', XbaI site underlined) were used to amplify from pJPF2 the DNA encoding the first 28 amino acids of ChiA . DNA amplification and fragment isolation were performed as described above . The DNA fragment was ligated into pGEM-T (Promega, Madison, Wis.) . pGEM-chiA(1-28) was digested with SacI and XbaI, and the fragment encoding the ChiA signal peptide was subsequently ligated into pBluescript SKII+ . The chiA sequence of pchiA(1-28) was confirmed by nucleotide sequencing . Blue-619 was used as the downstream oligonucleotide primer to engineer all seven N-terminal truncations . The upstream oligonucleotide for each truncation was synthesized with an in-frame XbaI restriction site (underlined) . The nucleotide sequences of the upstream oligonucleotides were as follows: chiAN66, 5'-CCTCTAGAGGTCAATGGGACGCA-3'; chiAN75, 5'-AATCTAGAGGACAGTGTGACGG-3'; chiAN125, 5'-CCTCTAGAGGATTACAAGCCAATGC-3'; chiAN180, 5'-CGTCTAGAGTGACGTTGACTAGC-3'; chiAN225, 5'-TTTCTAGAATCGATAGCTCTGAGCCT-3'; chiAN276, 5'-GCTCTAGATTACCTGTGTATTCGGTG-3'; and chiAN429, 5'-ATTCTAGAGTTTCACTGACTTCACCGA3' . DNA amplifications and fragment isolation were performed as described earlier . Amplified DNA fragments were digested with XbaI and HindIII and ligated into pchiA(1-28) at equivalent sites . The junction between chiA(1-28) and each N-terminal truncation was confirmed by nucleotide sequencing . Fragments were oriented so that expression of the mutant genes was under control of Plac .
After transformation of the plasmids into E . coli DH5 Engineering of MalE-ChiA-E-tag fusion protein, ChiA(75-555), and other ChiA mutants. Construction of pJL1, the plasmid encoding the MalE-ChiA-E-tag chimera, has been described (5) . Plasmids encoding ChiA(75-555), ChiA(C77A), and ChiA(C537A) were engineered by PCR . To engineer ChiA(75-555), the two synthetic oligonucleotides used for the N- and C-terminal truncation studies, ChiAN75 and ChiAC555, were used as primers to amplify the specific DNA fragment from pTDCC2 . Conditions for PCR were denaturation at 92°C for 30 s, annealing at 54°C for 45 s, and extension at 72°C for 2 min . Amplified DNA fragments were resolved by electrophoresis on 0.8% agarose gels, isolated from gel slices using a GeneClean kit, and digested with XbaI and HindIII for subsequent ligation into pchiA(1-28) . The DNA fragment was oriented in-frame with respect to the natural ChiA signal peptide encoded by pchiA(1-28) and downstream of the vector's Plac . To engineer ChiA(C77A), primer Blue-619 and primer chiA(C77A) (5'-AATCTAGAGGACAGGCGGACGGAG-3', XbaI site underlined, nucleotide change in italic; identical in sequence to primer chiAN75 with the exception of a three-nucleotide change at amino acid position 77 of wild-type ChiA) were used to amplify an internal region of chiA from pJPF2 encoding amino acids 75 to 846 of ChiA with an alanine for cysteine substitution at amino acid position 77 (C77A) . The DNA fragment encoding the C77A mutation was digested with XbaI and HindIII and ligated into pchiA(1-28) to fuse the gene sequences in-frame to the chiA signal sequence . To engineer ChiA(C537A), primer Blue-619 and ChiA(C537A) (5'-TCAAGCTTTTAACGAATTGGCGCACCCGCA-3', HindIII site underlined, stop codon in bold, and nucleotide change in italic) were used to amplify an internal region of chiA from pTDCC2, which encodes amino acids 1 to 540, but substituted with an alanine for cysteine at amino acid position 537 (C537A) . The amplification reaction also incorporated an in-frame TAA translational stop codon at the 3' end of the sequence . The DNA fragment encoding the C537A mutation was digested with XbaI and HindIII and ligated into pBluescript SKII+ . Nucleotide sequencing confirmed the sequence of the entire coding region of pchiA(75-555) and the cysteine to alanine mutation of both mutants, pchiA(C77A) and pchiA(C537A) .
All three recombinant plasmids [pchiA(75-555), pchiA(C77A), and pchiA(C537A)] were transformed into E . coli DH5 Preparation of culture supernatant and periplasmic extract. Culture supernatant and periplasmic extract were obtained from bacteria grown to an optical density at 600 nm (OD600) of 0.9 to 1.4 (6) . In brief, bacterial cultures were centrifuged to separate cells and culture supernatant . Sodium azide was added to the culture supernatant at a final concentration of 0.05% (wt/vol) to inhibit continuing growth of residual viable cells . Pelleted cells, resuspended in phosphate-buffered saline (PBS) containing 1 mM EDTA and 1 mg of polymyxin B sulfate per ml, were incubated at 37°C for 30 min to release periplasmic contents . The cell suspensions were centrifuged to separate the periplasmic extract from the extracted cells . SDS-PAGE and Western analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting were performed as previously described (5) . Isoelectric focusing grade acrylamide and bisacrylamide were purchased from Pharmacia Biotech (Uppsala, Sweden) . Proteins were resolved by SDS-PAGE in 8.75% gels and electrophoretically transferred to nitrocellulose filters, and the filters were immunoblotted with rabbit anti-MalE-ChiA-E-tag antiserum (1:15,000) and horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (1:10,000; Sigma Biochemicals) using previously established procedures (5) . Immunoblots were developed using a Renaissance Western blot chemiluminescence kit (Dupont/New England Nuclear, Wilmington, Del.) . Fluorescent signals were detected by exposure of the immunoblots on Biomare Blue-sensitive autoradiographic film (Marsh Biomedical Products, Inc., Rochester, N.Y.) . DNA sequencing. Double-stranded DNA sequencing was performed by the Sequencing Facility of the Center for Applied Molecular Biology and Immunology at the State University of New York at Buffalo or by the Biopolymer Facility at the Roswell Park Cancer Institute (Buffalo, N.Y.) . The synthetic, single-stranded oligonucleotide Blue-619 was used to prime the sequencing reactions . Measurement of ß-lactamase activity. When appropriate, ß-lactamase activity was used to confirm that the cells in cultures were intact and that polypeptides found in the culture supernatant were not derived from cell lysis . Culture supernatant and periplasmic extract were prepared as previously described (6) . Extract was added to a solution of nitrocefin (Becton Dickinson Microbiology Systems, Cockeysville, Md.) (51.6 µg/ml in 0.05 M phosphate buffer at pH 7.0), and the mixture was measured for increasing absorbency over a 5-min interval at OD482 using a Beckman DU series 600 spectrophotometer (Fullerton, Calif.) . ß-Lactamase activity was calculated by the method of O'Callaghan et al . (21) .
To investigate whether either terminus of ChiA was essential for secretion, a chimeric protein was engineered that fused MalE of E . coli to the N terminus of the protein and a 13-amino-acid epitope tag (E-tag) (Pharmacia Biotech) to the C terminus of the protein (Fig . 1) . When the plasmid (pJPL1) encoding the chimera was transformed into E . coli DH5
To investigate whether the presence of extracellular chimera was derived from cell lysis, culture supernatant and periplasmic extract of 569B(chiA::Kanr)(pJL1) and 569B(chiA::Kanr)(pmal-p2) were measured for ß-lactamase, a periplasmic enzyme produced by the plasmid-encoded blaM gene . Less than 3% of the total ß-lactamase activity was detected in the culture supernatant, confirming that cellular lysis was only a minor contributor to the presence of extracellular polypeptide . Secretion of the chimera depended on an intact eps-encoded transport system. Although it had been shown previously (5) that ChiA was secreted by the eps-encoded MTB, it was certainly feasible that the MalE-ChiA-E-tag chimera had been transported via an alternative secretory system which had been coopted by the cell . To confirm that secretion of the chimeric ChiA polypeptide by the cell was eps dependent and to provide further evidence that cell lysis was not a contributing factor, pJL1 was transformed into V . cholerae N16961 and into its epsD (secretion deficient) mutant NS1 (1) . When the transformants were analyzed for secretion of the chimera, the MalE-ChiA-E-tag chimera was observed in the culture supernatant of N16961(pJL1), but not in the culture supernatant of NS1(pJL1) (Fig . 2C) . As observed for 569B(chiA::Kanr)(pJL1), both full-size and smaller degraded forms of the chimera were detected in the periplasmic extracts of both strains, indicating that the lower efficiency of secretion of the chimera was not strain dependent . Nonetheless, it was concluded from these data that, as observed for secretion of wild-type ChiA, secretion of the chimeric MalE-ChiA-E-tag protein by V . cholerae required an intact eps-encoded MTB . Secretion of N- and C-terminally truncated mutants of ChiA. Since previous experiments confirmed that neither the natural N terminus nor C terminus of ChiA was essential for secretion of ChiA, it was reasonable to hypothesize that amino acid sequences located internal to the termini were important for secretion recognition . To delimit the regions of ChiA which were involved in secretion recognition, a nested set of N-terminal and C-terminal truncations of ChiA was engineered (Fig . 1) . Mutant ChiA polypeptides truncated from the amino-terminal end were designated by the letter N; mutant ChiA polypeptides truncated from the carboxyl-terminal end were denoted by the letter C (e.g., N66 is a mutant ChiA comprised of amino acids 66 to 846, while C756 is a mutant polypeptide comprised of amino acids 1 to 756.) Since the N-terminal mutants required a signal peptide to direct translocation into the periplasmic space of the cell, all genes encoding N-terminal truncations were fused to nucleotide sequences encoding the native sec-dependent signal peptide of ChiA, including its natural signal peptidase cleavage site (amino acids 1 to 28) . Seven N-terminal truncations of ChiA (N66, N75, N125, N180, N225, N276, and N429) and six C-terminal truncations of ChiA (C756, C608, C555, C478, C378, and C179) were engineered . Plasmids encoding the N-terminally truncated mutant ChiA polypeptides were transformed into 569B(chiA::Kanr), and culture supernatant and periplasmic extract were analyzed by immunoblotting for ChiA immunoreactivity . As expected, wild-type ChiA was efficiently secreted by 569B(chiA::Kanr)(pJPF2) (Fig . 3A and 3B) . Of the seven N-terminal mutants, however, only mutant ChiA polypeptides N66 and N75 were observed in the culture supernatant (Fig . 3A) . For mutant ChiA polypeptides truncated to amino acid 125 (N125) and beyond (N180, N225, and N276), all immunoreactive protein was confined to the periplasmic extract (Fig . 3A) . The smallest N-terminal truncation, N429, was also restricted to the periplasmic fraction, although the polypeptide was expressed at exceptionally low levels (data not shown) .
Initially, the secretion characteristics of C608 were difficult to interpret, as the major immunoreactive polypeptide ( Taken together, the results for the N-terminal and the C-terminal mutants established that the essential information required to promote extracellular transport of ChiA by V . cholerae was located between amino acids 75 and 555 (schematically represented in Fig . 1) . Secretion of mutant ChiA(75-555). To confirm that the region bounded by amino acids 75 to 555 was sufficient to promote extracellular secretion of ChiA, an N- and C-terminally truncated mutant ChiA polypeptide was engineered that was comprised of only amino acids 75 to 555 fused to the endogenous ChiA signal peptide (Fig . 1) . Culture supernatant of 569B(chiA::Kanr)[pchiA(75-555)] was found to contain a 53-kDa immunoreactive polypeptide, which was consistent with the predicted molecular mass of the mutant polypeptide (Fig . 4A) . Less than 6% of the total ß-lactamase activity was located in the culture supernatant, confirming that the presence of immunoreactive ChiA(75-555) in the culture supernatant was the result of active secretion by the cell and not a result of autolysis .
Secretion competence of chitinase A mutants C77A and C537A. Mature ChiA contains nine cysteines, some of which are likely involved in forming disulfide bonds (Fig . 5) . Disulfide bonds are commonly crucial for maintaining the structural integrity of exported proteins (19) . It was concluded from the results of the truncated ChiA polypeptides that three of the cysteines (Cys579, Cys774, and Cys801) were not essential for secretion, as these residues are located outside of the 75 to 555 region of ChiA . In contrast, Cys77 and Cys537 are located immediately within the termini of ChiA(75-555) . It was deemed feasible that Cys77 and Cys537 participated in disulfide bond formation either with each other or with one of the four other cysteines (Cys273, Cys300, Cys306, and Cys332) and that those disulfide bonds in ChiA were essential for secretion activity . This model was consistent with our results, in which all of the ChiA mutants which were truncated beyond amino acids 75 and 555 were secretion deficient .
As an initial approach to identifying the ETS of ChiA, a fusion strategy was used to determine if the N or C terminus of the protein was essential for secretion (Fig . 1) . Since MalE is not secreted by V . cholerae, this protein was chosen as the N-terminal fusion partner for ChiA, and a small E-tag epitope was chosen as the initial C-terminal fusion partner . Secretion studies using this chimera provided strong evidence that, unlike secretion of polygalacturonase by E . carotovora (23), secretion of ChiA did not require the exposure of either of the natural termini (Fig . 2B) . The MalE-ChiA-E-tag chimera and wild-type ChiA, however, were not secreted with equivalent efficiency by V . cholerae (Fig . 2A) . Considerable amounts of immunoreactive chimera were retained in the periplasmic space . To address the issue of whether the large amount of chimera in the periplasm was due simply to overloading of the eps-encoded secretory machinery, we decreased the expression levels of wild-type ChiA and the MalE-ChiA-E-tag chimera by use of lower-copy-number vectors and by altering the induction conditions, respectively . Reducing the expression of the recombinant genes had no detectable effect on the relative distribution of these polypeptides (data not shown) . Alternatively, several other factors could be responsible for the less efficient extracellular transport of the chimera from the periplasm . An improperly folded ChiA would exhibit an improperly folded ETS, which would likely be recognized with much lower efficiency by the eps-encoded secretion machinery . In that regard, it is possible that the MalE portion of the MalE-ChiA-E-tag polypeptide interferes with efficient folding of the ChiA portion of the chimera . Second, it cannot be discounted that the size of the chimera (128 kDa) relative to the size of wild-type ChiA (88 kDa ) may have an adverse affect on the ability of the MTB of V . cholerae to transport the protein . In support of this hypothesis is the observation that 569B(chiA::Kanr) was incapable of secreting either a PhoA-ChiA chimera or a BlaM-ChiA chimera (data not shown) . The failure of Klebsiella oxytoca to secrete a PhoA-pullulanase chimera was also attributed to size incompatibility (13) . Since the experiments confirmed that neither the N nor the C terminus of ChiA was required to promote secretion, we addressed the alternative hypothesis that the ETS activity was encoded by amino acids located internal to the termini . To locate these amino acids, a series of ChiA mutants with increasing N-terminal and C-terminal truncations were engineered (Fig . 1) . These experiments were complicated, however, by the sensitivity of the mutant ChiA polypeptides to in vivo degradation . Degradation was particularly evident for the C-terminal truncations, for which a major 53-kDa degradation product was observed in the culture supernatants of cells expressing mutant C756 and mutant C608 (Fig . 3) . In contrast, this 53-kDa derivative polypeptide was not observed in the culture supernatants of any of the N-terminal truncation mutants (Fig . 3) . This pattern of degradation suggested to us that the proteolytic cleavage that produces the 53-kDa polypeptide occurs at a site near the C terminus of ChiA . We are currently investigating whether this common degradation product is, itself, proficient for secretion, and thus exhibits an active ETS . Alternatively, the 53-kDa polypeptide could be produced in the culture supernatant by extracellular proteolysis of a larger, secreted progenitor . Although smaller degradation products were often the major immunoreactive forms in the cells, prospective mutant ChiA polypeptides having the proper predicted molecular masses were always evident in the immunoblots of culture supernatants and/or periplasmic extracts . In some cases, however, large amounts of sample had to be loaded onto the SDS-polyacrylamide gels used for the immunoblots to detect the properly sized mutant ChiA polypeptide (data not shown) . The N- and C-terminal truncation studies revealed that the functional ETS of ChiA was likely located between amino acids 75 and 555 . To confirm that this region was independently sufficient to promote secretion, a mutant ChiA polypeptide comprising only amino acids 75 to 555 was engineered and shown to be secreted by V . cholerae (Fig . 1), thus demonstrating that the structural information for secretion competence of ChiA was located solely within the region bounded by amino acids 75 and 555 (Fig . 4A) . Expression of the ChiA(75-555) mutant polypeptide in NS1, a secretion-deficient, epsD mutant strain of V . cholerae (Fig . 4B) established that, as is observed for wild-type ChiA, secretion of the ChiA(75-555) mutant polypeptide was dependent upon the eps-dependent extracellular transport system . Disulfide bonds are often an important contributor to the proper folding and stability of extracellular proteins . The mutant ChiA(75-555) polypeptide contained two cysteines which were located immediately within the terminal boundaries (Cys77 and Cys537) . To test whether Cys77 and/or Cys537 contributed to ETS activity, mutant ChiA polypeptides were engineered in which the cysteines were independently replaced with alanines (Fig . 1) . Fractionation experiments showed that secretion of the ChiA polypeptides was unaffected by substitution of either amino acid (Fig . 6) . The constraints, if any, that the other four cysteines (Cys273, Cys,300, Cys306, and Cys332) located within the 75 to 555 region have on ETS activity has yet to be elucidated . To investigate the predicted secondary and tertiary structure of ChiA, the amino acid sequence of ChiA was analyzed using the ProDom (7) and SMART (31, 32) databases . ChiA was predicted to contain three types of structural domains: (i) two type III chitin-binding domains (CBD3), (ii) three type III fibronectin-like (Fn3-like) domains, and (iii) a catalytic domain (Fig . 5) . Our experiments have confirmed that the catalytic domain of ChiA is localized proximal to the C terminus and downstream of the amino acid position 555 boundary (Fig . 5) (unpublished data) . These data provided strong evidence that the catalytic domain of ChiA is not involved in ETS activity . A role of the Fn3-like domains of ChiA in ETS activity, however, is more likely . Fn3-like domains are hypothesized to encompass strong and stable secondary protein structures that interact with other Fn3-like domains or with other structural domains located elsewhere in a polypeptide . These interactions are believed to promote and maintain the proper conformation of the protein (35) . Interestingly, all three Fn3-like domains of ChiA (85 to 180, 336 to 423, and 429 to 528) are located within the 75 to 555 region of the protein (Fig . 5) . Two of the three Fn3-like domains (85 to 180 and 429 to 528) of ChiA occur immediately within the boundaries of amino acids 75 to 555 . Based on our observations and the pattern of Fn3-like domain distribution, one could hypothesize that the ETS of ChiA is encoded entirely by one or both of these terminally located Fn3-like domains . A more plausible hypothesis, however, is that the two Fn3-like domains (85 to 180 and 429 to 528) promote the proper folding and spacing of the ETS, which is located elsewhere in the protein . Mutant ChiA polypeptides which are deleted for one or more of the Fn3-like domains are currently being engineered to investigate the role of these regions in extracellular secretion of the protein . In E . chrysanthemi, two nonadjacent regions of pectate lyase C are required for its extracellular transport (14) . Similarly, secretion of a ß-lactamase-pullulanase fusion protein by K . oxytoca was shown to require the expression of two nonadjacent 80-amino-acid regions of the pullulanase polypeptide (30) . While it is possible that the ETS of ChiA is composed entirely of the 480-amino-acid region encompassed by amino acids 75 and 555, an equally plausible hypothesis is that, as for the ETS of pectate lyase and pullulanase, the ETS of ChiA consists of two nonadjacent regions of ChiA, one of which is located immediately beyond amino acid 75 and the other of which is located immediately adjacent to amino acid 555 . To investigate the latter model, we are currently engineering mutant ChiA polypeptides which are deleted for a significant region of the protein located between amino acids 75 and 555 . To complement these continuing genetic studies, the three-dimensional structure of wild-type ChiA is being resolved . Upon completion of these genetic and structural investigations, the precise nature of the structural motif comprising the ETS of ChiA will finally be revealed . Several important human pathogens, including P . aeruginosa (9, 10), A . hydrophila (3, 34), and V . cholerae (22, 28), employ the MTB to transport a variety of survival and virulence proteins to the extracellular milieu . With the possible exception of pullulanase (25) and exotoxin A (10), the current study of ChiA is the most extensive genetic analysis of a secreted protein to identify the amino acid sequences which constitute a bacterial ETS . Our effort to identify the ETS of ChiA is an important step toward the goal of defining the precise molecular interactions that occur between extracellular proteins of V . cholerae and the components of the eps-encoded secretion machinery .
This work was supported by research grant R29AI37817 from the National Institutes of Health to T.D.C . and by funds from the School of Medicine and Biomedical Sciences at the State University of New York at Buffalo .
What Is Growth Medium?,
What Is Botulism?,
What Is Rhizobia?,
What Is Water Purification?,
What Is Bioremediation?,
c,
Microorganisms,
o,
Microbiology,
e,
Microbes,
i,
Microbe,
o,
Bacteriology,
a,
Escherichia coli,
r,
Staphylococcus,
c,
Escherichia coli,
n,
Rhizobacter,
e,
Streptococcal,
c,
Yeasts,
a,
Neisseria,
c,
Bacillus,
n,
Staphylococcus,
n,
Haemophilus,
s,
Escherichia coli,
o,
Vancomycin,
s,
Escherichia coli,
o,
Microbial,
i,
Microbiological,
r,
Cell cultures,
a,
Cholera,
s,
Candida albicans,
r,
Escherichia coli,
e,
Bacillus subtilis,
a,
S. cerevisiae
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||